A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
Sensex
78,151.45
▲ +1.25%
Nifty
24,334.30
▲ +1.09%
22k Gold
₹ 13,065/gm
Silver
₹ 2,30,000/kg
Petrol
₹ 111.18
Diesel
₹ 97.83
LPG
₹ 941.50
Crude Oil
$ 86.03
USD
₹ 96.28
Sensex
78,151.45
▲ +1.25%
Nifty
24,334.30
▲ +1.09%
22k Gold
₹ 13,065/gm
Silver
₹ 2,30,000/kg
Petrol
₹ 111.18
Diesel
₹ 97.83
LPG
₹ 941.50
Crude Oil
$ 86.03
USD
₹ 96.28
ITI Pharma and Healthcare Fund - Direct Plan
Regular
Direct
3 Year Absolute Returns
79.04% ↑
NAV (₹) on 16 Jul 2026
19.39
1 Day NAV Change
0.01%
Risk Level
Very High Risk
Rating
-
ITI Pharma and Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by ITI Asset Management Limited. Launched on 18 Oct 2021, investors can start with a minimum SIP ... Read more
NAV History
Fund Details
Min. SIP Amount
₹500
Inception Date
18 Oct 2021
Min. Lumpsum Amount
₹ 5,000
Fund Age
4 Yrs
AUM
₹ 251.87 Cr.
Benchmark
NIFTY Healthcare Total Return Index
Expense Ratio
0.95%
Scheme Type
Open Ended
Exit Load
0.5%
Returns Calculator
Investment amount per month
₹1,000
Over the past
Would have become
On total investment of
*Calculation based on past performance of this fund.
Asset Allocation
AUM
₹ 251.87 Cr
Equity
589.81%
Other Assets & Liabilities
10.19%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 70.80% |
| Hospitals & Medical Services | 20.23% |
| Net Receivables/(Payables) | 3.22% |
| Medical Equipment & Accessories | 1.28% |
| Industrial Gases | 1.25% |
| Plastics - Plastic & Plastic Products | 1.22% |
| Steel - Tubes/Pipes | 0.95% |
| Aerospace & Defense | 0.54% |
| Finance - Banks - Private Sector | 0.51% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | 13.34% | ₹ 33.60 | Pharmaceuticals |
| Divi's Laboratories Limited | 6.79% | ₹ 17.10 | Pharmaceuticals |
| Apollo Hospitals Enterprise Limited | 6.22% | ₹ 15.66 | Hospitals & Medical Services |
| Dr. Reddy's Laboratories Limited | 5.44% | ₹ 13.69 | Pharmaceuticals |
| Max Healthcare Institute Limited | 5.41% | ₹ 13.63 | Hospitals & Medical Services |
| Cipla Limited | 4.60% | ₹ 11.58 | Pharmaceuticals |
| Torrent Pharmaceuticals Limited | 4.56% | ₹ 11.47 | Pharmaceuticals |
| Laurus Labs Limited | 4.40% | ₹ 11.09 | Pharmaceuticals |
| Aurobindo Pharma Limited | 4.10% | ₹ 10.33 | Pharmaceuticals |
| Lupin Limited | 3.30% | ₹ 8.31 | Pharmaceuticals |
| Net Receivables / (Payables) | 3.22% | ₹ 8.19 | Others |
| Neuland Laboratories Limited | 3.09% | ₹ 7.78 | Pharmaceuticals |
| Fortis Healthcare Limited | 2.94% | ₹ 7.41 | Hospitals & Medical Services |
| Cohance Lifesciences Limited | 2.89% | ₹ 7.29 | Pharmaceuticals |
| Mankind Pharma Limited | 2.84% | ₹ 7.16 | Pharmaceuticals |
| Alkem Laboratories Limited | 2.75% | ₹ 6.94 | Pharmaceuticals |
| Global Health Limited | 2.01% | ₹ 5.07 | Hospitals & Medical Services |
| Abbott India Limited | 1.82% | ₹ 4.58 | Pharmaceuticals |
| Aster DM Healthcare Limited | 1.54% | ₹ 3.87 | Hospitals & Medical Services |
| IPCA Laboratories Limited | 1.52% | ₹ 3.83 | Pharmaceuticals |
| Sai Life Sciences Limited | 1.30% | ₹ 3.26 | Pharmaceuticals |
| Poly Medicure Limited | 1.28% | ₹ 3.21 | Medical Equipment & Accessories |
| Linde India Limited | 1.25% | ₹ 3.14 | Industrial Gases |
| Shaily Engineering Plastics Limited | 1.22% | ₹ 3.06 | Plastics - Plastic & Plastic Products |
| Shilpa Medicare Limited | 1.18% | ₹ 2.97 | Pharmaceuticals |
| Piramal Pharma Limited | 1.14% | ₹ 2.86 | Pharmaceuticals |
| Glenmark Pharmaceuticals Limited | 1.12% | ₹ 2.83 | Pharmaceuticals |
| Healthcare Global Enterprises Limited | 1.09% | ₹ 2.74 | Hospitals & Medical Services |
| Supriya Lifescience Limited | 1.03% | ₹ 2.58 | Pharmaceuticals |
| Rainbow Childrens Medicare Limited | 1.02% | ₹ 2.57 | Hospitals & Medical Services |
| Biocon Limited | 0.97% | ₹ 2.45 | Pharmaceuticals |
| Venus Pipes And Tubes Limited | 0.95% | ₹ 2.40 | Steel - Tubes/Pipes |
| GlaxoSmithKline Pharmaceuticals Limited | 0.90% | ₹ 2.26 | Pharmaceuticals |
| Zydus Lifesciences Limited | 0.74% | ₹ 1.87 | Pharmaceuticals |
| Caplin Point Laboratories Limited | 0.59% | ₹ 1.49 | Pharmaceuticals |
| Bharat Dynamics Limited | 0.54% | ₹ 1.35 | Aerospace & Defense |
| Yes Bank Limited | 0.51% | ₹ 1.28 | Finance - Banks - Private Sector |
| Syngene International Limited | 0.39% | ₹ 0.98 | Pharmaceuticals |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 9.00% | 7.07% | 11.32% | 21.43% |
| Category returns | 3.36% | 4.49% | 6.16% | 22.44% |
Fund Objective
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. ... Read more
AMC Details
Name
ITI Asset Management Limited
Date of Incorporation
14 May 2018
CEO
Mr. Jatinder Pal Singh
CIO
Mr. Rajesh Bhatia
Type
Pvt.Sector-Indian
Address
ITI House 36,
Dr. R. K. Shirodkar Marg,
Parel Mumbai, Maharashtra, India - 400012
Website
https://www.itiamc.com
Email
Top Funds from Equity - Sectoral/Thematic
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹34.94 | 150.72% | 264.87% | 0.00% | ₹1,192 | 1.30% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹34.94 | 150.72% | 264.87% | 0.00% | ₹1,192 | 1.30% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹34.94 | 150.72% | 264.87% | 0.00% | ₹1,192 | 1.30% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹32.69 | 147.32% | 250.04% | 0.00% | ₹1,192 | 2.60% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹32.69 | 147.32% | 250.04% | 0.00% | ₹1,192 | 2.60% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹32.69 | 147.32% | 250.04% | 0.00% | ₹1,192 | 2.60% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹29.95 | 17.92% | 180.60% | 0.00% | ₹10,529 | 0.87% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹29.95 | 17.92% | 180.60% | 0.00% | ₹10,529 | 0.87% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹29.95 | 17.92% | 180.60% | 0.00% | ₹10,529 | 0.87% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹28.93 | 16.75% | 171.42% | 0.00% | ₹10,529 | 1.80% |
Very High
|
Top Funds from ITI Asset Management Limited
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
ITI Small Cap Fund - Direct Plan
Diversified
Direct
|
₹36.85 | 12.77% | 102.27% | 123.22% | ₹3,322 | 0.84% |
Very High
|
|
ITI Small Cap Fund
Diversified
Regular
|
₹32.71 | 11.09% | 92.86% | 104.43% | ₹3,322 | 2.19% |
Very High
|
|
ITI Small Cap Fund - Direct Plan
Diversified
Direct
|
₹34.93 | 10.49% | 91.75% | 111.61% | ₹3,322 | 0.84% |
Very High
|
|
ITI Small Cap Fund - Direct Plan
Diversified
Direct
|
₹34.93 | 10.49% | 91.75% | 111.61% | ₹3,322 | 0.84% |
Very High
|
|
ITI Mid Cap Fund - Direct Plan
Diversified
Direct
|
₹25.51 | 9.19% | 86.33% | 120.04% | ₹1,446 | 1.10% |
Very High
|
|
ITI Small Cap Fund
Diversified
Regular
|
₹30.84 | 8.57% | 81.84% | 92.74% | ₹3,322 | 2.19% |
Very High
|
|
ITI Small Cap Fund
Diversified
Regular
|
₹30.84 | 8.57% | 81.84% | 92.74% | ₹3,322 | 2.19% |
Very High
|
|
ITI Pharma and Healthcare Fund - Direct Plan
Sector
Direct
|
₹19.39 | 7.08% | 79.06% | 0.00% | ₹252 | 0.95% |
Very High
|
|
ITI Pharma and Healthcare Fund - Direct Plan
Sector
Direct
|
₹19.39 | 7.07% | 79.04% | 0.00% | ₹252 | 0.95% |
Very High
|
|
ITI Mid Cap Fund
Diversified
Regular
|
₹22.99 | 7.48% | 76.96% | 99.99% | ₹1,446 | 2.60% |
Very High
|
FAQs
What is the current NAV of ITI Pharma and Healthcare Fund - Direct Plan IDCW-Reinvestment?
The current Net Asset Value (NAV) of ITI Pharma and Healthcare Fund - Direct Plan IDCW-Reinvestment is ₹19.39 as of 16 Jul 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of ITI Pharma and Healthcare Fund - Direct Plan IDCW-Reinvestment?
The Assets Under Management (AUM) of ITI Pharma and Healthcare Fund - Direct Plan IDCW-Reinvestment is ₹251.87 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of ITI Pharma and Healthcare Fund - Direct Plan IDCW-Reinvestment?
ITI Pharma and Healthcare Fund - Direct Plan IDCW-Reinvestment has delivered returns of 7.07% (1 Year), 21.43% (3 Year), 0.00% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of ITI Pharma and Healthcare Fund - Direct Plan IDCW-Reinvestment?
ITI Pharma and Healthcare Fund - Direct Plan IDCW-Reinvestment has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for ITI Pharma and Healthcare Fund - Direct Plan IDCW-Reinvestment?
The minimum lumpsum investment required for ITI Pharma and Healthcare Fund - Direct Plan IDCW-Reinvestment is ₹5,000. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹500, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
-
ವಿದೇಶಿ ಮ್ಯೂಚುವಲ್ ಫಂಡ್ ಹೂಡಿಕೆದಾರರೇ ಗಮನಿಸಿ: ಹೊಸ ಎಸ್ಐಪಿ ನೋಂದಣಿ ಸ್ಥಗಿತ, ನಿಮ್ಮ ಹಣದ ಮೇಲೆ ಪರಿಣಾಮವೇನು? -
ಮ್ಯೂಚುವಲ್ ಫಂಡ್ ಹೂಡಿಕೆದಾರರೇ ಎಚ್ಚರ! ಜುಲೈ 13ರಿಂದ ಬದಲಾಗಲಿದೆ ಎಕ್ಸ್ಪೆನ್ಸ್ ರೇಶಿಯೋ, ನಿಮ್ಮ ಲಾಭಕ್ಕೆ ಕತ್ತರಿ ಬೀಳುತ್ತಾ? -
ಎಸ್ಐಪಿ ಹೂಡಿಕೆಯಲ್ಲಿ ಹೊಸ ದಾಖಲೆ: ನಿಮ್ಮ ಹಣವನ್ನು ಎಲ್ಲಿ ಹೂಡಿಕೆ ಮಾಡಿದರೆ ಹೆಚ್ಚು ಲಾಭ? -
ಮ್ಯೂಚುವಲ್ ಫಂಡ್ ಹೂಡಿಕೆಯಲ್ಲಿ ಹೊಸ ಇತಿಹಾಸ: ಜೂನ್ 2026ರಲ್ಲಿ ಎಸ್ಐಪಿ ಹರಿವು ₹25,000 ಕೋಟಿ ದಾಟಿದೆ! -
ಹೂಡಿಕೆದಾರರಿಗೆ ಹೊಸ ಅವಕಾಶ: TRUSTMF ಲಾರ್ಜ್ ಮತ್ತು ಮಿಡ್ ಕ್ಯಾಪ್ ಫಂಡ್ ಎನ್ಎಫ್ಒ ಆರಂಭ! -
HDFC ನಿಫ್ಟಿ ಆಟೋ ಇಂಡೆಕ್ಸ್ ಫಂಡ್ NFO: ಇಂದೇ ಕೊನೆಯ ದಿನ, ಹೂಡಿಕೆದಾರರಿಗೆ ಸಿಗಲಿದೆ ಭರ್ಜರಿ ಲಾಭ? -
ರಥಯಾತ್ರೆ ರಜೆ: ಇಂದು ನಿಮ್ಮ ಎಸ್ಐಪಿ ಹಣ ಕಟ್ ಆಗುತ್ತಾ? ಹೂಡಿಕೆದಾರರೇ ಗಾಬರಿಯಾಗಬೇಡಿ! -
ಸೆಬಿ ಹೊಸ ನಿಯಮ: ಮ್ಯೂಚುವಲ್ ಫಂಡ್ ಹೂಡಿಕೆದಾರರಿಗೆ ಭರ್ಜರಿ ಗುಡ್ ನ್ಯೂಸ್, ನಿಮ್ಮ SIP ಮೇಲೆ ಏನು ಪರಿಣಾಮ? -
ಮ್ಯೂಚುವಲ್ ಫಂಡ್ ಹೂಡಿಕೆಯಲ್ಲಿ ನೀವು ಮಾಡುತ್ತಿರುವ ದೊಡ್ಡ ತಪ್ಪು: ಲಕ್ಷಾಂತರ ರೂಪಾಯಿ ಉಳಿಸುವುದು ಹೇಗೆ? -
ನಿಫ್ಟಿ ಸ್ಮಾಲ್ಕ್ಯಾಪ್ 250 ಎನ್ಎಫ್ಒ: ಹೂಡಿಕೆಗೂ ಮುನ್ನ ಈ ರಿಸ್ಕ್ ಬಗ್ಗೆ ನಿಮಗೆ ಗೊತ್ತಾ?
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+